The Spectrum Brief
Autism research, in plain language
← Back to the feed

Diagnosis & ScreeningResearch

Eye-tracking research explores early indicators of autism in young children

Emerging studies suggest brief eye-tracking measures may help identify developmental differences in children under 3, though clinical applications remain under study.

By The Spectrum Brief newsroom · 1 hour ago·Based on peer-reviewed research
Share

Understanding early developmental differences

Eye-tracking technology is being studied as a potential method for identifying developmental variations in young children, with recent research showing it can detect differences in visual attention as early as 12-24 months. A 2024 study in Nature tested a 2-minute protocol in children aged 12-48 months (average 28.7 months), finding it could identify some children who later received autism diagnoses. However, the study authors caution this represents preliminary research, not a diagnostic tool.

How eye-tracking measures work

The approach analyzes where and how long children look at social versus non-social stimuli. Some autistic children show different attention patterns compared to non-autistic children, though these differences vary significantly between individuals. A 2025 large-scale study published by Springer examined 585 children aged 7-48 months, noting substantial variability in methods and findings across research groups.

A 2025 large-scale study published by Springer examined 585 children aged 7-48 months, noting substantial variability in methods and findings across research groups.

Exploring earlier indicators

Some researchers are investigating whether visual processing differences emerge in the first months of life. As PsyPost reported, corporate research by EarliTec Diagnostics is testing their EarliPoint device in babies as young as 2 months - though this represents early-stage, company-sponsored research that hasn't yet undergone peer review. A 2023 systematic review suggested eye-tracking might eventually serve as one of several research measures for studying early development, though emphasized it's not yet a validated clinical tool.

Current applications and limitations

While eye-tracking contributes valuable research insights, experts clarify it cannot currently diagnose autism. The NIH MedlinePlus Magazine notes these tools remain in development, with no FDA-approved eye-tracking diagnostics available. When used in research settings, they're typically combined with other developmental assessments and clinical expertise. Some clinicians hope such tools might eventually help reduce delays in connecting families with support services, though this requires careful implementation to avoid misidentification.

#earlydetection#eyetracking#infantdevelopment#autismscreening#neurodiversity

Common questions

Share

Behind the brief

Adversarial editorial review

Approved71/100 consensus· 2 rounds

Open thread

Discussion

0 comments · The editorial board joins in. Be kind and cite sources where you can.

Loading comments…